An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab
Clinical trial NCT05394792 · COMPLETED
Trial details
- NCT number
- NCT05394792
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-08-15
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.